(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
5 days till quarter result
(bmo 2024-05-02)
Expected move: +/- 0.00%
2.26% SEK 29.40
Live Chart Being Loaded With Signals
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments...
Stats | |
---|---|
Dzisiejszy wolumen | 219 728 |
Średni wolumen | 422 520 |
Kapitalizacja rynkowa | 14.98B |
EPS | SEK0 ( 2024-02-15 ) |
Następna data zysków | ( SEK0.330 ) 2024-05-02 |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | 133.64 |
ATR14 | SEK0.0970 (0.33%) |
Wolumen Korelacja
Vimian Group AB (publ) Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Vimian Group AB (publ) Korelacja - Waluta/Towar
Vimian Group AB (publ) Finanse
Annual | 2023 |
Przychody: | SEK331.73M |
Zysk brutto: | SEK229.43M (69.16 %) |
EPS: | SEK0.0194 |
FY | 2023 |
Przychody: | SEK331.73M |
Zysk brutto: | SEK229.43M (69.16 %) |
EPS: | SEK0.0194 |
FY | 2022 |
Przychody: | SEK281.31M |
Zysk brutto: | SEK193.99M (68.96 %) |
EPS: | SEK-0.0179 |
FY | 2021 |
Przychody: | SEK173.35M |
Zysk brutto: | SEK80.31M (46.33 %) |
EPS: | SEK0.0200 |
Financial Reports:
No articles found.
Vimian Group AB (publ)
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, and education and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and orthopedic implants for veterinarians and universities under the Movora brand name. The company was incorporated in 2020 and is headquartered in Stockholm, Sweden.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej